Innovative nanotechnology prototype for recombinant vaccines
Principal investigator
Project type
Znanstveno-istraživački projekti
Programme
NextGenerationEU
Financier
European Union
Start date
Jan 17th 2025
End date
Apr 17th 2026
Status
Done
Total cost
65994 EUR
More information
The project utilises genetic engineering to design and laboratory-produce recombinant antigens. Modern methods of computational chemistry and molecular analysis will be used to assess the activation of the immune response to the synthesised antigen.